# The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer

> **NCT05082636** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 90 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Observational Study ( Tissue Biopsy )

## Key facts

- **NCT ID:** NCT05082636
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-15
- **Primary completion:** 2020-06-20
- **Final completion:** 2021-03-25
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082636, "The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05082636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*